Reviewed by: 69Fun Health Editors
Clinical Guideline Standard: ATA / AACE 2026 Reference Protocol
Most people know Graves’ disease for rapid weight loss, heat intolerance, and a racing heart. The eyes get less attention.
They shouldn’t. For up to 40% of patients, the autoimmune antibodies also target the retrobulbar tissues behind the eyes, producing Thyroid Eye Disease (TED).
Early Warning Indicators of Active Orbital Inflammation
Watch for these four signs:
- Persistent gritty sensation: It feels as though sand or dust is trapped behind your eyelids, and standard lubricating drops don’t help.
- Spontaneous retrobulbar aching: A dull, deep pressure or ache behind the eyeballs, particularly worse when you wake up in the morning.
- Gaze-evoked pain: Discomfort when looking upward or to the side, which signals inflammation of the extraocular muscles.
- Mild diplopia (double vision): Blurring or ghosting of images when driving or reading.
You can evaluate your clinical activity score with our validated 7-point Thyroid Eye Disease (TED) CAS Screener.
Frequently Asked Questions
Q: How does Graves’ disease affect the eyes?
A: The same autoimmune process behind Graves’ disease can target the tissues behind the eyes. That relates to thyroid hormone receptor binding, peripheral deiodinase conversion, and metabolic homeostasis, and proper timing and physician oversight are essential.
Q: What should I do if I notice these eye signs?
A: Endocrinologists recommend comprehensive serum testing, including TSH, Free T3, Free T4, and antibodies, and optimizing micronutrient cofactors such as selenium, zinc, and ferritin. Adjust medication spacing only under direct medical supervision, and get eye symptoms checked promptly.
This article is for educational purposes only and is not medical advice. Please see your doctor about your own testing and treatment.